Raymond James & Associates’s Kindred Healthcare KND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-25,150
Closed -$230K 3714
2018
Q1
$230K Buy
+25,150
New +$233K ﹤0.01% 3062
2016
Q3
Sell
-15,721
Closed -$177K 3346
2016
Q2
$177K Sell
15,721
-1,466
-9% -$18.4K ﹤0.01% 2696
2016
Q1
$212K Buy
+17,187
New +$178K ﹤0.01% 2543

Other funds holding KND

Raymond James & Associates's KND Position: Q2 2018 in Review

Raymond James & Associates sold out of Kindred Healthcare (KND) in Q2 2018, closing a stake of 25,150 shares — an estimated $230K sold.

Raymond James & Associates first reported a position in KND in Q1 2016 and held it in 3 quarters. The position peaked at $230K in Q1 2018. 149 funds tracked by Wall St. Rank hold KND as of Q2 2018.

  • Raymond James & Associates reported no remaining Kindred Healthcare position as of Q2 2018 after selling out during the quarter.
  • Raymond James & Associates sold 25,150 Kindred Healthcare shares in Q2 2018, an estimated $230K.
  • Raymond James & Associates first reported a position in Kindred Healthcare in Q1 2016 and held it in 3 quarters.
  • Raymond James & Associates's Kindred Healthcare position peaked at $230K in Q1 2018.
  • 149 funds tracked by Wall St. Rank held Kindred Healthcare as of Q2 2018.

Based on Raymond James & Associates's 13F filing for Q2 2018, filed 14 Aug 2018.